Ports and airports should expose informative materials on symptoms and MPOX prevention measures. Posters should be placed in the areas of international landing, while the emergence of public health of international importance for the disease lasts.
Similarly, the airlines should issue a beep on measles aboard the aircraftwhile the process of eliminating the disease in Brazil lasts.
On international flights, the message with guidelines on the disease should also be announced in Spanish and English. The disease is declared as a public health event in Brazil.
The measures were determined by the National Health Surveillance Agency (Anvisa) and are part of the new normative instruction of the organwhich deals with the temporary health actions to be adopted in ports, airports and by means of transport, in the face of the epidemiological scenario in the country.
The document was approved by Anvisa’s collegiate principal last Monday (28/07).
Informative materials and health measures will be adopted for declared diseases as an emergency of public health (ESPI), emergency of public health (ESPIN) and public health event (ESP).
For MPOX and measles only the measures of dissemination of the informative materialsthere is no recommendation of specific health measures related to travelers or means of transport.
In addition to the two diseases, the Polio is also on the international public health emergency list of international importance, but no health or informative material measure need to be adopted.
Normative instruction is periodically updated based on the epidemiological alerts of national and international public health events. The epidemiological scenario is updated regularly, based on guidelines of the Ministry of Health’s Public Health Monitoring Committee (CME), Active Health Emergency Operation Centers, as well as technical and normative guidelines issued by the Ministry of Health.
According to Anvisa, the approval of the standard is a legacy of the Covid-19 pandemic, When different resolutions were required requiring exams, facial masks and other measures to reduce disease transmission to ports and airports.
“Now the agency implements an agile instrument, which allows you to update these measures as soon as the Ministry of Health indicate its application and its technical relevance to the sector is verified.”
Illnesses
MPOX is caused by the monkeypox virus And it can spread between people and occasionally from the environment to people, through objects and surfaces that were touched by an infected patient.
Your most common symptom It is the rash on the skin, similar to bubbles or wounds, which can last two to four weeks. The current warning for MPOX is related to the new strain 1b of the virus that is circulating in Africa It was identified in Brazil in March.
Already the measles is a disease Highly contagious viral, caused by paramixoviruses that is transmitted by the air directly, through secretions expelled to coughing, sneezing, speaking or breathing, and can remain in environments for two hours.
Infection can lead to serious complications such as otitis media, pneumonia, infertility in male individuals and encephalitis. The alert in force was issued after new cases and outbreaks of measles of international circulation and isolated cases in Brazil identified even after disease elimination certification in the country.
THE polio is also caused by a virus that can infect children and adults through direct contact with feces or secretions eliminated by the mouth of sick people And in severe cases it is able to invade the central nervous system and cause paralysis in the lower limbs.
The World Health Organization Evaluates that there is still the risk of international propagation of poliovirus.
Vaccines against polio and measles are available in the public network health.
For MPOX in 2023, during the first global emergency, Anvisa authorized emergency use of the Jynneos vaccine for a specific audience.
THE development of a national immunizer It is a priority of the virus network, a Virology specialist committee created for the development of diagnostics, treatments, vaccines and content production on emerging viruses in Brazil.
